Videos
Cardiac Kids: Late-Stage Advancement for Cardiovascular Disorders KOL Panel
In this panel companies discuss developments in the broader market, as well as their unique late-stage drugs looking to address cardiac-based indications. Panelists include Quang Pham, Chairman & CEO at Cadrenal Therapeutics and Craig Fraser, CEO at Windtree...
Windtree Therapeutics, Inc. (WINT) Company Webcast
Windtree Therapeutics, Inc. is advancing late-stage interventions for cardiovascular disorders to treat patients in moments of crisis. Using new scientific and clinical approaches, Windtree is developing a multi-asset franchise anchored around compounds with an...